The Bridge Assisted Living Life Care Center of Greeley

A revisit survey was completed on 8/6/25 for all previous deficiencies cited on 2/13/25. The facility is in compliance with all deficiencies that were cited. Citation coded "0000" or "9999" are initial and final comments of an inspection for informational purposes, this field may also have been left blank intentionally

A relicensure survey with complaint #CO38526 was completed on 2/13/25. Deficiencies were cited. Based on interview and record review, the residence failed to be responsible for the coordination of resident care services with known external service providers (ESPs), affecting two of two sample residents who required testing for a urinary tract infection (#2, #4). (Cross-reference S2230)Findings Include:Resident #4 was admitted to the residence on 6/23/2023 with a diagnosis of urine retention.A progress note, dated 1/4/24, read: "Resident says she has a burning sensation when urinating and thinks she has a (urinary tract infection) UTI." A practitioner' s visit note, dated 1/8/25, contained no information about the residence reporting that the resident had a burning sensation when urinating or t.. Based on interview and record review, the residence failed to ensure resident records contained progress notes, which included documentation regarding any out-of-the-ordinary event or issue that affects a resident' s physical, behavioral, cognitive and/or functional condition, along with the action taken by staff to address that resident' s changing needs, affecting three of six sample residents (#2, #4, #6). (Cross-reference S1412)Findings include:Resident #2 was admitted to the residence on 7/21/21.A progress note, dated 1/11/25 read in part the resident was discovered on the floor near his recliner. Due to the fall the resident care director (RCD) requested that the resident' s family member request uri.. Based on record review and interview the residence failed to comply with authorized practitioner orders associated with medication administration affecting two out of five sample residents (#3, #5).Findings include:Resident #5 was admitted to the residence on 11/12/24 with a diagnosis of mild cognitive impairment.A practitioner' s order read that clopidogrel bisulfate oral tablet was to be administered once daily in the evenings.A medication administration record (MAR) for Resident #5 dated January of 2025 recorded clopidogrel bisulfate was not administered on 1/13 to 1/21/25, due to the medication being unavailable, for a total of 13 missed doses.Resident #5 also went without the following .. Based on record review and interview, the residence failed to develop and implement policies and procedures for the identification, reporting, and investigation of injuries of unknown origin, affecting 60 current residents.Findings include:The residence Incident Report policy, dated 8/24/22, was provided by the residence when the Injury of Unknown Origin policy was requested. However, the policy failed to contain all of the required elements such as identifying, documenting, reporting and investigating injuries of unknown origin.Resident #2 was admitted to the residence on 7/21/21 with a diagnosis of Alzheimer ' s Disease with late onset, dementia and senile degeneration of t.. THIS PORTION OF THE REPORT IS FOR INFORMATIONAL PURPOSES ONLY.No response is necessary.The residence was advised it must review and maintain the following processes in accordance with existing program regulations found at 6 CCR 1011-1, Chapter 7.14.33 The assisted living residence shall ensure that the resident ' s authorized practitioner and resident ' s legal representative are promptly notified of:(A) A decline from a resident ' s baseline status;(B) A resident ' s pattern of refusal;(C) A resident ' s repetitive request for and use of PRN medication;(D) Any observed or reported unfavorable reactions to medications;(E) The administration of medications used to emergently treat angin..

A revisit survey was completed on 11/14/24 for all previous deficiencies cited on 7/30/24. The facility is in compliance with all deficiencies that were cited. Citation coded "0000" or "9999" are initial and final comments of an inspection for informational purposes, this field may also have been left blank intentionally

A licensure complaint, prompted by #CO36919 and #CO36960, was completed on 7/30/24. Deficiencies were cited. Based on observation, record review, and interview, the residence failed to prohibit a qualified medication administration person (QMAP) from pre-pouring medication, affecting one current resident (#4).Findings include:1. Residence Policy The residence' s Medication Management policy, dated 8/22/22, read in part: "Medications are stored in the original dispensing containers/packaging. State laws require labels to be intact and legible. (QMAPs) cannot write on labels."2. ObservationOn 7/30/24 at 7:47 a.m., a shelf within the medication cart contained one clear cup, not labeled, that held five small clear packages, each labeled with military time, medication name, and Reside.. Based on record review and interview the residence failed to properly identify the right medication with the right resident, affecting one former resident (#5). (Cross-reference S1612)1. Residence PolicyThe residence' s Medication Management policy, dated 8/22/22, read in part: "The resident care director is responsible for ensuring oversight and supervision for following physician orders."2. Record Review Former Resident #5 was admitted to the residence on 10/5/24 with diagnoses including polymyalgia rheumatica.A nursing visit note from an external service provider (ESP), dated 7/20/24 at 6:25 a.m., read in part that the residence requested assistance with a large laceration on Former R.. Based on record review and interview, the residence failed to be responsible for complying with authorized practitioner orders associated with medication administration, except for those medications which a resident self-administers, affecting two of four sample residents (#2, #3). (Cross-reference S1612)Findings include:1. Residence PolicyThe residence' s Medication Management policy, dated 8/22/22, read in part: "The resident care director is responsible for ensuring oversight and supervision for following physician orders."2. Record ReviewResident #3 was admitted to the residence on 5/30/24 with diagnoses including disorder of the kidney and ureter, hypertensive heart.. Based on record review and interview, the residence failed to ensure that the resident' s legal representative was promptly notified of a medication error that affected the resident, affecting one former resident (#4). (Cross-reference S1568)Findings include:1. Record Review Former Resident #5 was admitted to the residence on 10/5/23 with diagnoses including polymyalgia rheumatica. An incident report, dated 7/20/24, read in part that Staff #4 administered Resident #3' s medication to Former Resident #5.A nursing visit note from an external service provider (ESP), dated 7/20/24 at 6:25 a.m., read in part: "Notified patient' s daughter of a wound and new orders for pain man.. THIS PORTION OF THE REPORT IS FOR INFORMATIONAL PURPOSES ONLY.No response is necessary.The residence was advised it must review and maintain the following processes in accordance with existing program regulations found at 6 CCR 1011-1, Chapter 2 and at 6 CCR 1011-1, Chapter 7.2.3.6. Applicants must show compliance with the Colorado Adult Protective Services Data System (CAPS Check) requirements as set forth in section 26-3.1-111, C.R.S. 7.1 In order to ensure that staff members and volunteers are of good, moral, and responsible character, the assisted living residence shall request, prior to staff hire or volunteer on-boarding, a name-based criminal history rec..

A revisit survey was completed on 8/30/23 for all previous deficiencies cited on 3/14/23. The facility is in compliance with all deficiencies that were cited. Citation coded "0000" or "9999" are initial and final comments of an inspection for informational purposes, this field may also have been left blank intentionally

A revisit survey was completed on 8/30/23 for all previous deficiencies cited on 3/14/23. The facility is in compliance with all deficiencies that were cited. Citation coded "0000" or "9999" are initial and final comments of an inspection for informational purposes, this field may also have been left blank intentionally

A licensure revisit was completed on 3/14/23 for all previous deficiencies cited on 10/7/22. A deficiency was cited. Based on observation, interview and record review, the residence failed to comply with authorized practitioner orders associated with medication administration, affecting six of six sample residents (#25, #27-29, and #31-#32). This deficiency was cited previously during a state licensure survey 10/7/22. Although the facility corrected the deficiency, based on the findings below, the facility has not maintained compliance with this regulatory requirement.Findings include:1. Residence PolicyThe residence' s Medication Management policy, revised 8/22/22, read in part: the residence was responsible for ensuring oversight and supervision for following physician orders.2. Resident #25 was admitted to the residence on 6/27/22 with diagnoses including chronic myeloid leukemia, long-term use of anticoagulants, hypothyroidism, hypertension, restless legs and hyperlipidemia.a. GleevecA written practitioner' s order, dated 10/25/22, directed the residence to administer two 100 milligram (mg) tablets of Gleevec once daily. However, the January and March 2023 medication administration record (MAR) revealed the medication was not administered on 1/1/23, 1/14-1/15/23, 1/17-1/19/23, 1/21-1/22/23, and 1/25-1/29/23, 1/31/23, and 3/1-3/2/23 for a total of 15 missed doses due to the medication being unavailable. On 3/14/23 at 3:28 p.m., the administrator stated that the pharmacy did not keep Gleevec in stock, so it was not administered until the residence was able to obtain the medication from an outside pharmacy.b. Nitrofurantoin Monohyd MacroA written practitioner' s order for Nitrofurantoin Monohyd Macro 100 mg every 12 hours, dated 3/8/23, was discontinued on 3/8/23. However, the March 2023 MAR revealed administer Nitrofurantoin Monohyd Macro on 3/9/23 in the evening, 3/10/23 in the morning, 3/11/23 both doses, 3/12/23 in the evening, 3/13/23 both doses, and 3/14/23 in the morning, for a total of 8 doses.On 3/14/23 at 3:30 p.m., the administrator stated Nitrofurantoin Monohyd Macro was prescribed for a suspected urinary tract infec..